Obrigado por baixar o white paper, "Sinergizando inovação e proteção: estratégias para uma colaboração eficaz entre P&D e PI not setor farmacêutico."
O white paper foi enviado para o seu endereço de e-mail. Se você não recebê-la, poderá baixá-la diretamente clicando no botão abaixo.

Latest from CAS Insights™

Drug Discovery
How AI-driven analysis can accelerate drug discovery
Spiro[2.3]hexanes are an example of promising yet challenging scaffold structures for new drug compounds. By using AI-powered predictive analytics with CAS BioFinder, researchers more efficiently identified candidates for validation.

P&D digital
Five Markers of AI Readiness in R&D
AI-powered solutions hold so much potential for faster scientific innovation, but there are key milestones organizations must achieve before they can move beyond the pilot phase. These five markers are the cornerstones of AI readiness.
.avif)
Emerging Science
Point-of-care testing: faster diagnosis, easier access to care
Point-of-care testing goes beyond pandemic-era viral infection tests to bring faster diagnostics for infectious diseases, chronic conditions, cancer, and more.